In muscle tear models, the combination addresses both the inflammatory response and the structural repair phase simultaneously with BPC-157 modulating pro-inflammatory cytokines (TNF-, IL-6) and oxidative stress markers, and TB-500 recruiting progenitor cells and mesenchymal cells to the post-injury site while BPC-157 drives their subsequent differentiation and organisation
Are there risks with DSIP
Drug treatments that change the underlying biology of Alzheimer's The drugs lecanemab (Leqembi ) and donanemab (Kisunla ) change the underlying biology of Alzheimer's disease by targeting and removing betaamyloid from the brain
It increases the number of synaptic vesicles at the presynaptic terminal, boosts postsynaptic receptor responsiveness, and increases the overall number of synapses per neuron
Duzel, A., Vlainic, J., Antunovic, M., Malekinusic, D., Vrdoljak, B., Samara, M., Gojkovic, S., Krezic, I., Vidovic, T., Bilic, Z., Knezevic, M., Sever, M., Lojo, N., Kokot, A., Kolovrat, M., Drmic, D., Vukojevic, J., Kralj, T., Kasnik, K.,
